Company Summary - Dongbao Bio (SZ 300239) announced on September 2 that it has repurchased approximately 10.57 million shares through a special securities account via centralized bidding, accounting for 1.7812% of the company's current total share capital [1] - The maximum transaction price for the repurchased shares was 5.71 CNY per share, while the minimum transaction price was 4.59 CNY per share, with a total transaction amount of approximately 56.11 million CNY [1] - As of the report date, Dongbao Bio's market capitalization stands at 3.4 billion CNY [1] Financial Performance - For the fiscal year 2024, Dongbao Bio's revenue composition is entirely from biological and biochemical products, with a 100.0% share [1]

Group 1 - Dongbao Biological (SZ 300239) announced on August 29 that its 12th meeting of the 9th board of directors was held on August 28, 2025, in Baotou, where the proposal to revise the "Information Disclosure Management System" was reviewed [1] - For the year 2024, Dongbao Biological's revenue composition is 100.0% from biological and biochemical products [1]